ImmunArray Overview

  • Founded
  • 2005

  • Status
  • Out of Business

  • Employees
  • 30

  • Latest Deal Type
  • Out of Business

ImmunArray General Information


Developer of an in-vitro molecular diagnostics system designed to help physicians manage complex autoimmune and neurologic diseases. The company's system is used in the development of microarray devices and informatics that are used in profiling a patient's immune system to detect autoimmune, lung cancer, and other diseases, providing physicians with information from proprietary multi-analyte biomarker-based tests.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 12 Hamada Street
  • Entrance A - Floor 2
  • Rehovot 7670315
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunArray Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Sep-2020 000.00 Completed Out of Business
7. Later Stage VC (Series B) 11-Jul-2016 0000 000.00 Completed Generating Revenue
6. Grant 23-Jan-2014 00000 00.00 Completed Generating Revenue
5. Later Stage VC 15-Apr-2013 00.00 00.00 Completed Generating Revenue
4. Early Stage VC 03-May-2010 00.00 00.00 Completed Startup
3. Grant 22-Dec-2008 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 25-Feb-2008 Completed Startup
To view ImmunArray’s complete valuation and funding history, request access »

ImmunArray Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of an in-vitro molecular diagnostics system designed to help physicians manage complex autoimmune and neurolog
Diagnostic Equipment
Rehovot, Israel
30 As of 2016
00000000 00 000.00


nt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
0000000000 000000000
San Carlos, CA
00 As of 0000
00000 00000 000


xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000 000000000
Irvine, CA
000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunArray Competitors (58)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InCellDx Venture Capital-Backed San Carlos, CA 00 000 00000 00000 000
0000000 Venture Capital-Backed Irvine, CA 000 00000 00000000
0000000 0000000000 Venture Capital-Backed Beverly, MA 00 00.00 0000000000 0 00.00
000000 0000000000 Venture Capital-Backed Frederick, MD 00 0000 0000000000 0000
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
You’re viewing 5 of 58 competitors. Get the full list »

ImmunArray Patents

ImmunArray Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180231565-A1 Methods for determining the risk of a systemic lupus erythematosus (sle) patient to develop neuropsychiatric syndromes Inactive 09-Aug-2015 00000000000

ImmunArray Executive Team (12)

Name Title Board Seat Contact Info
Nathan Hunt Vice President, Quality & Regulatory and Market Manager Neurological Diseases
You’re viewing 1 of 12 executive team members. Get the full list »

ImmunArray Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial